Connecting metabolic syndrome and metainflammation to neuroinflammation and neurodegeneration through the PTN/RPTPβ/ζ signalling pathway (METABNEUR)

Funding period: 2022-2025

Funding Agency: Ministry of Science and Innovation (PID2021-123865OB-I00)

Principal Investigator: Pilar Ramos and Gonzalo Herradón

Regulation by phosphorylation of androgen receptor stability in spinobulbar muscular atrophy

Funding period: 2018-2022

Funding Agency: CEU-Banco Santander

Principal Investigator: Maria José Polanco Mora

Characterising neuroinflammatory markers and other biomarkers of disease

Funding period: 2019-2022

Funding Agency: King’s College London and Glaxo Smith Kline (GSK)

Principal Investigator: Diana Cash y Marta Vicente Rodríguez

Preclinical evaluation of the selective RPTPβ/ζ receptor inhibitor (MY10) in modulating the immune response in Alzheimer’s disease

Funding period: 2021-2023

Funding Agency: CEU-Banco Santander

Principal Investigator: Marta Vicente Rodríguez

Role of the Pleiotrophin/Receptor Protein Tyrosine Phosphatase beta/zeta signalling pathway in inflammatory processes involved in metabolic and neurodegenerative disorders

Funding period: 2019-2021

Funding Agency: Ministerio de Ciencia e Innovación (RTI2018-095615-B-I00)

Principal Investigator: Pilar Ramos y Gonzalo Herradón